UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epidemiology of alcoholic and nonalcoholic fatty liver disease in China

Journal of gastroenterology and hepatology, 2013-08, Vol.28 (S1), p.11-17

Fan, Jian-Gao

2013

Volltextzugriff (PDF)

Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease

Journal of clinical and translational hepatology, 2020-03, Vol.8 (1), p.13-17

2020

Volltextzugriff (PDF)

Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota

Scientific reports, 2017-05, Vol.7 (1), p.1529-11, Article 1529

2017

Volltextzugriff (PDF)

The global burden of liver disease: The major impact of China

Hepatology (Baltimore, Md.), 2014-12, Vol.60 (6), p.2099-2108

2014

Volltextzugriff (PDF)

Microbial metabolites in non-alcoholic fatty liver disease

World journal of gastroenterology : WJG, 2019-05, Vol.25 (17), p.2019-2028

2019

Volltextzugriff (PDF)

Editorial: changes of health‐related quality of life associated with liver disease severity and its improvement after treatment in NAFLD

Alimentary pharmacology & therapeutics, 2023-01, Vol.57 (2), p.257-258

2023

Volltextzugriff (PDF)

Lipotoxic Hepatocyte‐Derived Exosomal MicroRNA 192‐5p Activates Macrophages Through Rictor/Akt/Forkhead Box Transcription Factor O1 Signaling in Nonalcoholic Fatty Liver Disease

Hepatology (Baltimore, Md.), 2020-08, Vol.72 (2), p.454-469

2020

Volltextzugriff (PDF)

The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

Hepatology international, 2020-12, Vol.14 (6), p.889-919

2020

Volltextzugriff (PDF)

Epidemiology of non-alcoholic fatty liver disease in China

Journal of hepatology, 2009-01, Vol.50 (1), p.204-210

2009

Volltextzugriff (PDF)

Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats

Experimental and Molecular Medicine, 2019, 51(0), , pp.1-14

2019

Volltextzugriff (PDF)

Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier

World journal of gastroenterology : WJG, 2017-01, Vol.23 (1), p.60-75

2017

Volltextzugriff (PDF)

Post-translational regulation of lipogenesis via AMPK-dependent phosphorylation of insulin-induced gene

Nature communications, 2019-02, Vol.10 (1), p.623-13, Article 623

2019

Volltextzugriff (PDF)

Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease

Hepatobiliary & pancreatic diseases international, 2017-08, Vol.16 (4), p.375-381

2017

Volltextzugriff (PDF)

Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression

Experimental and Molecular Medicine, 2018, 50(0), , pp.1-12

2018

Volltextzugriff (PDF)

From NAFLD to MAFLD: a "redefining" moment for fatty liver disease

Chinese medical journal, 2020-10, Vol.133 (19), p.2271-2273

2020

Volltextzugriff (PDF)

Role of diet and nutritional management in non-alcoholic fatty liver disease

Journal of gastroenterology and hepatology, 2013-12, Vol.28 (S4), p.81-87

2013

Volltextzugriff (PDF)

DEP domain–containing mTOR–interacting protein suppresses lipogenesis and ameliorates hepatic steatosis and acute‐on‐chronic liver injury in alcoholic liver disease

Hepatology (Baltimore, Md.), 2018-08, Vol.68 (2), p.496-514

2018

Volltextzugriff (PDF)

What are the clinical settings and outcomes of lean NAFLD?

Nature reviews. Gastroenterology & hepatology, 2021-05, Vol.18 (5), p.289-290

2021

Volltextzugriff (PDF)

Editorial: effect of hepatic steatosis on liver stiffness in patients with chronic hepatitis B—authors' reply

Alimentary pharmacology & therapeutics, 2019-08, Vol.50 (3), p.334-335

2019

Volltextzugriff (PDF)

Letter: moderate‐to‐severe hepatic steatosis leads to overestimation of liver stiffness measurement in chronic hepatitis B patients without significant fibrosis. Authors’ reply

Alimentary pharmacology & therapeutics, 2019-09, Vol.50 (5), p.617-618

2019

Volltextzugriff (PDF)

The hepato-ovarian axis: genetic evidence for a causal association between non-alcoholic fatty liver disease and polycystic ovary syndrome

BMC medicine, 2023-02, Vol.21 (1), p.62-62, Article 62

2023

Volltextzugriff (PDF)

Current status and challenges in the drug treatment for fibrotic nonalcoholic steatohepatitis

Acta pharmacologica Sinica, 2022-05, Vol.43 (5), p.1191-1199

2022

Volltextzugriff (PDF)

Potential epigenetic mechanism in non-alcoholic Fatty liver disease

International Journal of Molecular Sciences, 2015-03, Vol.16 (3), p.5161-5179

2015

Volltextzugriff (PDF)

1 – 25 von 719

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(536)
Mit Volltextzugriff
(586)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Epidemiology of alcoholic and nonalcoholic fatty liver disease in China

Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease

Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota

The global burden of liver disease: The major impact of China

Microbial metabolites in non-alcoholic fatty liver disease

Editorial: changes of health‐related quality of life associated with liver disease severity and its improvement after treatment in NAFLD

Lipotoxic Hepatocyte‐Derived Exosomal MicroRNA 192‐5p Activates Macrophages Through Rictor/Akt/Forkhead Box Transcription Factor O1 Signaling in Nonalcoholic Fatty Liver Disease

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

Epidemiology of non-alcoholic fatty liver disease in China

Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats

Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier

Post-translational regulation of lipogenesis via AMPK-dependent phosphorylation of insulin-induced gene

Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease

Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression

From NAFLD to MAFLD: a "redefining" moment for fatty liver disease

Role of diet and nutritional management in non-alcoholic fatty liver disease

DEP domain–containing mTOR–interacting protein suppresses lipogenesis and ameliorates hepatic steatosis and acute‐on‐chronic liver injury in alcoholic liver disease

What are the clinical settings and outcomes of lean NAFLD?

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

Editorial: effect of hepatic steatosis on liver stiffness in patients with chronic hepatitis B—authors' reply

Letter: moderate‐to‐severe hepatic steatosis leads to overestimation of liver stiffness measurement in chronic hepatitis B patients without significant fibrosis. Authors’ reply

The hepato-ovarian axis: genetic evidence for a causal association between non-alcoholic fatty liver disease and polycystic ovary syndrome

Current status and challenges in the drug treatment for fibrotic nonalcoholic steatohepatitis

Potential epigenetic mechanism in non-alcoholic Fatty liver disease

Suchergebnisse filtern